Impaired insulin sensitivity as an underlying mechanism linking hepatitis c and posttransplant diabetes mellitus in kidney recipients

American Journal of Transplantation

Volumn 9, Issue 12, 2009, Pages 2777-2784

  Baid Agrawal, S ^a   Frei, U ^a   Reinke, P ^a   Schindler, R ^a   Kopp, M A ^a   Martus, P ^b   Berg, T ^b   Juergensen, J S ^a   Anker, S D ^b   Doehner, W ^b  

^a Medical Intensive Care   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Hepatitis C virus (HCV); Insulin resistance; Kidney transplantation; Posttransplant diabetes mellitus (PTDM)

Indexed keywords

AZATHIOPRINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; CYCLOSPORIN A; DIURETIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; INTERLEUKIN 6; LYMPHOCYTE ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT RECIPIENT; HEPATITIS C; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; LIVER; MAJOR CLINICAL STUDY; MALE; PANCREAS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE TOLERANCE TEST; HEPATITIS C, CHRONIC; HUMANS; INSULIN; INSULIN RESISTANCE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 72449187501     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2009.02843.x     Document Type: Article

References (33)

1. Blackard JT, Kemmer N, Sherman KE. Extrahepatic replication of HCV: Insights into clinical manifestations and biological consequences. Hepatology 2006 44 : 15 22.
2. Allison ME, Wreghitt T, Palmer CR, Alexander GJ. Evidence for a link between hepatitis C virus infection and diabetes mellitus in a cirrhotic population. J Hepatol 1994 21 : 1135 1139.
3. Fraser GM, Harman I, Meller N, Niv Y, Porath A. Diabetes mellitus is associated with chronic hepatitis C but not chronic hepatitis B infection. Isr J Med Sci 1996 32 : 526 530.
4. Caronia S, Taylor K, Pagliaro L et al. Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 30 : 1059 1063.
5. Mason AL, Lau JY, Hoang N et al. Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology 1999 29 : 328 333.
6. Knobler H, Schihmanter R, Zifroni A, Fenakel G, Schattner A. Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection. Mayo Clin Proc 2000 75 : 355 359.
7. Zein NN, Abdulkarim AS, Wiesner RH, Egan KS, Persing DH. Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease. J Hepatol 2000 32 : 209 217.
8. Mehta SH, Brancati FL, Sulkowski MS, Strathdee SA, Szklo M, Thomas DL. Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States. Ann Intern Med 2000 133 : 592 599.
9. Lecube A, Hernandez C, Genesca J, Esteban JI, Jardi R, Simo R. High prevalence of glucose abnormalities in patients with hepatitis C virus infection: A multivariate analysis considering the liver injury. Diabetes Care 2004 27 : 1171 1175.
10. Knobler H, Stagnaro-Green A, Wallenstein S, Schwartz M, Roman SH. Higher incidence of diabetes in liver transplant recipients with hepatitis C. J Clin Gastroenterol 1998 26 : 30 33.
11. Baid S, Cosimi AB, Farrell ML et al. Posttransplant diabetes mellitus in liver transplant recipients: Risk factors, temporal relationship with hepatitis C virus allograft hepatitis, and impact on mortality. Transplantation 2001 72 : 1066 1072.
12. Baid S, Tolkoff-Rubin N, Farrell ML et al. Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: Role of hepatitis C infection. Transplant Proc 2002 34 : 1771 1773.
13. Bloom RD, Rao V, Weng F, Grossman RA, Cohen D, Mange KC. Association of hepatitis C with posttransplant diabetes in renal transplant patients on tacrolimus. J Am Soc Nephrol 2002 13 : 1374 1380.
14. Kasiske BL, Snyder JJ, Gilbertson D, Matas AJ. Diabetes mellitus after kidney transplantation in the United States. Am J Transplant 2003 3 : 178 185.
15. Abbott KC, Lentine KL, Bucci JR et al. Impact of diabetes and hepatitis after kidney transplantation on patients who are affected by hepatitis C virus. J Am Soc Nephrol 2004 15 : 3166 3174.
16. Fabrizi F, Martin P, Dixit V, Bunnapradist S, Kanwal F, Dulai G. Post-transplant diabetes mellitus and HCV seropositive status after renal transplantation: Meta-analysis of clinical studies. Am J Transplant 2005 5 : 2433 2440. (Pubitemid 43919427)
17. Kamar N, Toupance O, Buchler M et al. Evidence that clearance of hepatitis C virus RNA after alpha-interferon therapy in dialysis patients is sustained after renal transplantation. J Am Soc Nephrol 2003 14 : 2092 2098.
18. Aytug S, Reich D, Sapiro LE, Bernstein D, Begum N. Impaired IRS-1/PI3-kinase signaling in patients with HCV: A mechanism for increased prevalence of type 2 diabetes. Hepatology 2003 38 : 1384 1392.
19. Masini M, Campani D, Boggi U et al. Hepatitis C virus infection and human pancreatic beta-cell dysfunction. Diabetes Care 2005 28 : 940 941.
20. Kawaguchi T, Yoshida T, Harada M et al. Hepatitis C virus down-regulates insulin receptor substrates 1 and 2 through up-regulation of suppressor of cytokine signaling 3. Am J Pathol 2004 165 : 1499 1508.
21. Street A, Macdonald A, McCormick C, Harris M. Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription. J Virol 2005 79 : 5006 5016.
22. Shintani Y, Fujie H, Miyoshi H et al. Hepatitis C virus infection and diabetes: Direct involvement of the virus in the development of insulin resistance. Gastroenterology 2004 126 : 840 848.
23. Delgado-Borrego A, Casson D, Schoenfeld D et al. Hepatitis C virus is independently associated with increased insulin resistance after liver transplantation. Transplantation 2004 77 : 703 710.
24. Lopez R, Gentil MA, Acosta D et al. Minimal model analysis in nondiabetic renal transplant recipients with hepatitis C. Transplant Proc 2005 37 : 1446 1448.
25. Doehner W, Pflaum CD, Rauchhaus M et al. Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. Eur J Endocrinol 2001 145 : 727 735.
26. Bergman RN, Ider YZ, Bowden CR, Cobelli C. Quantitative estimation of insulin sensitivity. Am J Physiol 1979 236 : E667 E677.
27. Swan JW, Walton C, Godsland IF. Assessment of insulin sensitivity in man: A comparison of minimal model- and euglycaemic clamp-derived measures in health and heart failure. Clin Sci (Lond) 1994 86 : 317 322.
28. Doehner W, Anker SD, Godsland IF. Optimizing insulin sensitivity assessment using the minimal model in chronic heart failure. Horm Metab Res 2005 37 : 106 110.
29. Watanabe RM, Steil GM, Bergman RN. Critical evaluation of the combined model approach for estimation of prehepatic insulin secretion. Am J Physiol 1998 274 : E172 E183.
30. Walton C, Godsland IF, Proudler AJ, Felton C, Wynn V. Evaluation of four mathematical models of glucose and insulin dynamics with analysis of effects of age and obesity. Am J Physiol 1992 262 : E755 E762.
31. Petit JM, Bour JB, Galland-Jos C et al. Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C. J Hepatol 2001 35 : 279 283.
32. Lecube A, Hernandez C, Genesca J, Simo R. Proinflammatory cytokines, insulin resistance, and insulin secretion in chronic hepatitis C patients: A case-control study. Diabetes Care 2006 29 : 1096 1101. (Pubitemid 44115250)
33. Sheikh MY, Choi J, Qadri I, Friedman JE, Sanyal AJ. Hepatitis C virus infection: Molecular pathways to metabolic syndrome. Hepatology 2008 47 : 2127 2133.